Cillian O’Beirne

ORCID: 0000-0003-2195-026X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • N-Heterocyclic Carbenes in Organic and Inorganic Chemistry
  • Catalytic Cross-Coupling Reactions
  • Synthesis and Biological Evaluation
  • Antifungal resistance and susceptibility
  • Ferrocene Chemistry and Applications
  • Synthetic Organic Chemistry Methods
  • Catalytic Alkyne Reactions
  • Redox biology and oxidative stress
  • Enzyme function and inhibition
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Gut microbiota and health
  • Antimicrobial agents and applications
  • Fungal Infections and Studies
  • Peptidase Inhibition and Analysis
  • Organoboron and organosilicon chemistry
  • Quinazolinone synthesis and applications
  • Bacterial biofilms and quorum sensing
  • Asymmetric Hydrogenation and Catalysis
  • Click Chemistry and Applications
  • Metal complexes synthesis and properties

Université Paris Sciences et Lettres
2023

Centre National de la Recherche Scientifique
2023

University College Dublin
2016-2023

Chimie ParisTech
2023

Technische Universität Braunschweig
2023

The urgent need to combat antibiotic resistance and develop novel antimicrobial therapies has triggered studies on metal-based formulations. N-heterocyclic carbene (NHC) complexes coordinate transition metals generate a broad range of anticancer and/or agents, with ongoing efforts being made enhance the lipophilicity drug stability. lead silver(I) acetate complex, 1,3-dibenzyl-4,5-diphenylimidazol-2-ylidene (NHC*) (SBC3), previously demonstrated promising growth biofilm-inhibiting...

10.3390/antibiotics12020348 article EN cc-by Antibiotics 2023-02-08

The ongoing SARS-CoV-2 pandemic has caused a high demand for novel innovative antiviral drug candidates. Despite promising results, metal complexes have been relatively unexplored as agents in general and particular against SARS-CoV-2. Here we report on silver NHC with chloride or iodide counter ligands that are potent inhibitors of the papain-like protease (PLpro) but inactive 3C-like (3CLpro) another protease. Mechanistic studies selected complex confirmed zinc removal from binding domain...

10.1039/d3md00067b article EN cc-by-nc RSC Medicinal Chemistry 2023-01-01

The anticancer drug candidate 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene gold(I) chloride (NHC-AuCl) and its 2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl-1'-thiolate derivative (NHC-AuSR), which is a potential ligand for glucose transporters, were tested on the NCI 60 cancer cell panel in vitro. NHC-AuCl NHC-AuSR showed very good activity against wide range of human lines inclusive renal with similar average GI50 values 1.78 1.95 μM, respectively. This encouraged maximum tolerable dose...

10.2174/1570180813666160826100158 article EN Letters in Drug Design & Discovery 2016-09-09

Antibiotic resistance is a growing problem for public health and associated with increasing economic costs mortality rates. Silver silver-related compounds have been used centuries due to their antimicrobial properties. In this work, we show that 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate/NHC*-Ag-OAc (SBC3) reversible, high affinity inhibitor of E. coli thioredoxin reductase (TrxR; Ki =10.8±1.2 nM). Minimal inhibition concentration (MIC) tests different P. aeruginosa...

10.1002/cbic.202000707 article EN ChemBioChem 2020-11-10

The anticancer drug candidates 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene gold(I) dimethylamino dithiocarbamate and 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl-1-thiolate derivative exhibited nanomolar in-vitro activity against prostate cancer cells advanced (PC3) micromolar inhibition of mammalian thioredoxin reductase. Encouraging maximum tolerable dose experiments led to human subcutaneous xenograft experiments; were applied twelve times at two doses in groups n = 5 PC3 tumor-bearing...

10.1097/cad.0000000000000930 article EN Anti-Cancer Drugs 2020-04-08

N-heterocyclic silver carbene compounds have been extensively studied and shown to be active agents against a host of pathogenic bacteria fungi. By incorporating hypothesized virulence targeting substituents into NHC-silver systems via salt metathesis, an atom-efficient complexation process can used develop new complexes target the passive microbial cell. The incorporation fatty acids FtsZ inhibitor achieved, creation both intermediate subsequent complex has streamlined continuous flow...

10.1093/mtomcs/mfaa011 article EN Metallomics 2020-12-30

Drug resistance observed with many anti-infectives clearly highlights the need for new broad-spectrum agents to treat especially neglected tropical diseases (NTDs) caused by eukaryotic parasitic pathogens, including fungal infections. Herein, we show that simple modification of one most well-known antifungal drugs, fluconazole, organometallic moieties not only improves activity parent drug but also broadens scope application derivatives. These compounds were highly effective in vivo against...

10.1021/acs.jmedchem.3c01333 article EN Journal of Medicinal Chemistry 2023-11-27

Abstract The antimicrobial properties of silver have been exploited for many centuries and continue to gain interest in the fight against drug resistance. broad-spectrum activity low toxicity led its incorporation into a wide range novel agents, including N-heterocyclic carbene (NHC) complexes. vivo efficacy NHC silver(I) acetate complex SBC3, derived from 1,3-dibenzyl-4,5-diphenylimidazol-2-ylidene (NHC*), previously demonstrated, although mode(s) action SBC3 remains be fully elucidated....

10.1093/mtomcs/mfac046 article EN cc-by Metallomics 2022-01-01

Gold monochloride and monobromide can be transformed into monomeric complexes by ligands such as CO, PPh3 or Me2S, ligand-stabilized gold compounds have been investigated catalysts, luminescent materials anticancer drugs, especially when coordinated to a lipophilic benzyl-substituted N-heterocyclic carbene (NHC) ligand. The triclinic structures of NHC-Au-Cl {chlorido(1,3-dibenzyl-4,5-diphenylimidazol-2-ylidene)gold, [AuCl(C29H24N2)]} NHC-Au-Br...

10.1107/s2053229616015205 article EN Acta Crystallographica Section C Structural Chemistry 2016-10-05

Drug resistance observed with many anti-infectives clearly highlights the need for new broad-spectrum agents to treat especially neglected tropical diseases (NTDs) caused by eukaryotic parasitic pathogens including fungal infections. Since these target most vulnerable communities who are disadvantaged health and socio-economic factors, should be, if possible, easy-to-prepare allow commercialization based on their low cost. In this study, we show that simple modification of one well-known...

10.1101/2023.06.28.546819 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-06-30
Coming Soon ...